Podrobná bibliografia
| Názov: |
EMPOWER-Lung 1: Phase III first-line (1L) cemiplimab monotherapy vs platinum-doublet chemotherapy (chemo) in advanced non-small cell lung cancer (NSCLC) with programmed cell death-ligand 1 (PD-L1) >= 50% |
| Autori: |
Sezer, A., Kilickap, S., Gumus, M., Bondarenko, I., ÖZGÜROĞLU, Mustafa, Gogishvili, M., TÜRK, HACI MEHMET, Cicin, I., Bentsion, D., Gladkov, O., Clingan, P., Sriuranpong, V., Rizvi, N., Li, S., Lee, S., Gullo, G., Lowy, I., Rietschel, P. |
| Prispievatelia: |
TÜRK, HACI MEHMET |
| Informácie o vydavateľovi: |
2020. |
| Rok vydania: |
2020 |
| Predmety: |
Phase III first-line (1L) cemiplimab monotherapy vs platinum-doublet chemotherapy (chemo) in advanced non-small cell lung cancer (NSCLC) with programmed cell death-ligand 1 (PD-L1) >= 50%-, ESMO Virtual Congress, ELECTR NETWORK, 19 Eylül - 18 Ekim 2020, cilt.31 [Sezer A., Kilickap S., Gumus M., Bondarenko I., ÖZGÜROĞLU M., Gogishvili M., TÜRK H. M. , Cicin I., Bentsion D., Gladkov O., et al., -EMPOWER-Lung 1] |
| Druh dokumentu: |
Conference object |
| Popis súboru: |
application/pdf |
| DOI: |
10.1016/j.annonc.2020.08.2285 |
| Prístupová URL adresa: |
http://hdl.handle.net/20.500.12645/27357 |
| Prístupové číslo: |
edsair.od......9651..b9c354e94d941136bd7a6cf9710a1e52 |
| Databáza: |
OpenAIRE |
Nájsť tento článok vo Web of Science